Cargando…

Urinary BA Indices as Prognostic Biomarkers for Complications Associated with Liver Diseases

Hepatobiliary diseases and their complications cause the accumulation of toxic bile acids (BA) in the liver, blood, and other tissues, which may exacerbate the underlying condition and lead to unfavorable prognosis. To develop and validate prognostic biomarkers for the prediction of complications of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wenkuan, Alamoudi, Jawaher Abdullah, Gautam, Nagsen, Kumar, Devendra, Olivera, Macro, Gwon, Yeongjin, Mukgerjee, Sandeep, Alnouti, Yazen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986411/ https://www.ncbi.nlm.nih.gov/pubmed/35402050 http://dx.doi.org/10.1155/2022/5473752

Ejemplares similares

Bile acid indices as biomarkers for liver diseases II: The bile acid score survival prognostic model
por: Alamoudi, Jawaher Abdullah, et al.
Publicado: (2021)

Bile acid indices as biomarkers for liver diseases I: Diagnostic markers
por: Alamoudi, Jawaher Abdullah, et al.
Publicado: (2021)

Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet
por: Lu, Hong, et al.
Publicado: (2022)

ProTide generated long-acting abacavir nanoformulations
por: Lin, Zhiyi, et al.
Publicado: (2018)

Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir
por: Gautam, Nagsen, et al.
Publicado: (2021)

The Synergistic Effect of an ATP-Competitive Inhibitor of mTOR and Metformin on Pancreatic Tumor Growth
por: Soliman, Ghada A, et al.
Publicado: (2020)

Creation of a Long-Acting Nanoformulated 2′,3′-Dideoxy-3′-Thiacytidine
por: Guo, Dongwei, et al.
Publicado: (2017)

Pharmacokinetics of a Long-Acting Nanoformulated Dolutegravir Prodrug in Rhesus Macaques
por: McMillan, JoEllyn, et al.
Publicado: (2017)

Optimizing the preparation and stability of decorated antiretroviral drug nanocrystals
por: Zhou, Tian, et al.
Publicado: (2018)

Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles
por: Cobb, Denise A., et al.
Publicado: (2021)

Synthesis and characterization of a long-acting emtricitabine prodrug nanoformulation
por: Ibrahim, Ibrahim M, et al.
Publicado: (2019)

Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
por: Kanmogne, Georgette D, et al.
Publicado: (2012)

Creation of a long-acting nanoformulated dolutegravir
por: Sillman, Brady, et al.
Publicado: (2018)

Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
por: Zhou, Tian, et al.
Publicado: (2017)

Direct Comparison of Chol-siRNA Polyplexes and Chol-DsiRNA Polyplexes Targeting STAT3 in a Syngeneic Murine Model of TNBC
por: Ye, Zhen, et al.
Publicado: (2022)

Small-molecule IKKβ activation modulator (IKAM) targets MAP3K1 and inhibits pancreatic tumor growth
por: Napoleon, John Victor, et al.
Publicado: (2022)

Prediction of Stability during Walking at Simulated Ship’s Rolling Motion Using Accelerometers
por: Choi, Jungyeon, et al.
Publicado: (2022)

A Year-Long Extended Release Nanoformulated Cabotegravir Prodrug
por: Kulkarni, Tanmay A., et al.
Publicado: (2020)

Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
por: Deodhar, Suyash, et al.
Publicado: (2022)

Wearable Sensor-Based Prediction Model of Timed up and Go Test in Older Adults
por: Choi, Jungyeon, et al.
Publicado: (2021)

Role of social determinants of health in differential respiratory exposure and health outcomes among children
por: Puvvula, Jagadeesh, et al.
Publicado: (2023)

Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in mice
por: Alrehaili, Bandar D., et al.
Publicado: (2022)

Combinatorial assessments of brain tissue metabolomics and histopathology in rodent models of human immunodeficiency virus infection
por: Epstein, Adrian A., et al.
Publicado: (2013)

To BaP or not to BaP? That is the question.
por: Goldstein, L S
Publicado: (2001)

Cisplatin-loaded core cross-linked micelles: comparative pharmacokinetics, antitumor activity, and toxicity in mice
por: Oberoi, Hardeep S, et al.
Publicado: (2012)

Serum and urinary angiotensinogen levels as prognostic indicators in acute kidney injury: a prospective study
por: Akin, Ali, et al.
Publicado: (2023)

Complement Component 1, s Subcomponent Overexpression is an Independent Poor Prognostic Indicator in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary Bladder
por: Chang, I-Wei, et al.
Publicado: (2016)

Urinary indices in nephrotic syndrome
por: Sahay, M.
Publicado: (2011)

STRAIN IMAGING AS AN EARLY PROGNOSTIC INDICATOR FOR LATE COMPLICATIONS IN COVID-19 PATIENTS
por: Devera, Justin, et al.
Publicado: (2022)

Neutralization of Omicron BA.4/BA.5 and BA.2.75 by booster vaccination or BA.2 breakthrough infection sera
por: Wang, Xun, et al.
Publicado: (2022)

Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
por: Muik, Alexander, et al.
Publicado: (2022)

Urinary retention complicated by hematocolpos in an adolescent girl: Case report
por: Al-Buloushi, Noor, et al.
Publicado: (2023)

US FDA’s Assessment of the Benefit-risk of Cefiderocol for its Initial Complicated Urinary Tract Infection Indication
por: Echols, Roger M, et al.
Publicado: (2021)

Abdominal pseudocyst complicating ventriculoperitoneal shunt: A rare indication for ventriculopleural shunt conversion
por: Shrestha, Nishan, et al.
Publicado: (2023)

Omicron Waves in Argentina: Dynamics of SARS-CoV-2 Lineages BA.1, BA.2 and the Emerging BA.2.12.1 and BA.4/BA.5
por: Torres, Carolina, et al.
Publicado: (2023)

Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
por: Khan, Khadija, et al.
Publicado: (2022)

Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice
por: Muik, Alexander, et al.
Publicado: (2022)

Antibody evasion of SARS-CoV-2 Omicron BA.1, BA.1.1, BA.2, and BA.3 sub-lineages
por: Ai, Jingwen, et al.
Publicado: (2022)

Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5
por: Tseng, Hung Fu, et al.
Publicado: (2023)

Fabrication and Evaluation of W/O Emulsion Loaded with Linum usitatissimum Seeds Extract for Anti-Leishmaniasis Efficacy
por: Khan, Barkat Ali, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ngsl49v30hqiqju6r7abj0cq7j